A 2020 TOP DOC
Dr. John Campbell treats routine and complex foot and ankle disorders, including osteoarthritis, sprained ankle and Achilles tendinitis, as well as total ankle replacement.
Inflammatory bowel disease, or IBD, includes disorders that cause inflammation of the intestines. IBD is treated at Mercy by expert gastroenterologists.
The Breast Reconstruction and Restoration Center at Mercy is led by Dr. Bernard (Bernie) Chang, and Dr. Brendan Collins -recognized specialists in breast reconstruction and restoration.
Mercy offers emergency care on the Downtown Baltimore campus 24 hours a day, 7 days a week (410-332-9477) with access to a trained emergency medicine team, diagnostic services and consultations with specialists.
In case of an Emergency, Dial 911 and follow the instructions of the EMS (Emergency Medical Services) team.
Mercy Medical Center's downtown campus includes our Main Hospital - The Mary Catherine Bunting Center, McAuley Plaza and The Weinberg Center.
General visiting hours at Mercy are 11:00 am to 8:30 pm. Hours vary by floor, please check with the nursing staff or call 410-332-9555.
Currently Displaying: Active Clinical Trials
The purpose of this phase II trial is to determine the toxicity and post-operative complications related to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) as an initial treatment option for patients with ovarian, fallopian tube, or primary peritoneal cancers and its impact on quality of life. Subjects will be randomized to one of two treatment groups: CRS with HIPEC followed by combination chemotherapy, carboplatin and paclitaxel, or CRS only followed by combination chemotherapy carboplatin and paclitaxel.
Protocol Title and ClinicalTrials ID#:
A phase II randomized study: Outcomes after cytoreductive surgery (CRS) with or without carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) followed by systemic chemotherapy with carboplatin and paclitaxel as initial treatment of ovarian, fallopian tube, and primary peritoneal cancer. NCT02124421
The Ovarian Cancer Institute at Mercy is a National Center of Excellence located in Baltimore, Maryland, providing ovarian cyst treatment, ovarian mass treatment and ovarian cancer treatment to patients in Maryland, Virginia, Washington, D.C. and Pennsylvania — the Mid-Atlantic region. Our gynecologic surgeons are dedicated to helping patients find the best care, treatment and surgery options available for ovarian cancer and ovarian disease.
Mercy Medical Center is proud to have been recognized in the Best Hospitals edition of U.S. News & World Report.
Hyung S. Ryu, M.D., is a highly skilled gynecologic surgeon, providing treatment of ovarian, cervical and uterine cancers at Mercy.